Coronavirus

News

Moderna’s $37B market cap is too high, despite COVID-19 vacc...

JP Morgan has downgraded its valuation of Moderna, saying its $37 billion market cap is way too high even if its COVID-19 vaccine mRNA-1273 succeeds in clinical trials.

News

Coronavirus vaccine: how pharma is picking up the pace

‘Promising’ data on Oxford/AZ, CanSino coronavirus vaccines

Data from more than 1,000 healthy volunteers dosed with a coronavirus vaccine developed at Oxford University and AstraZeneca suggest the shot is safe and stimulates an immune r

News

Has-pharma-been-too-slow-to-respond-to-coronavirus

Japan trials app to help coronavirus patients recover at hom...

A smartphone app developed by medical software specialist Allm is being trialled in Japan to see if it can help patients with milder coronavirus symptoms recuperate at home, wi

News

Synairgen's inhaled drug cuts chances of COVID-19 progressin...

An inhaled drug developed by the UK firm Synairgen greatly reduces the chances of patients hospitalised with COVID-19 from progressing to more serious stages of the disease.

News

Call for COVID-19 'challenge trial' ahead of AstraZeneca vac...

Press reports suggest that there is good news about AstraZeneca and Oxford University’s COVID-19 vaccine due from an early stage trial in the coming days – but the focus is moving on how to

Views & Analysis

Coronavirus pharma news roundup - 17/07/20

Coronavirus vaccine trials continue – but experts warn that it’s too early to get hopes up. Meanwhile, the rise in digital health looks like it’s here to stay after the pandemic.

Moderna’s $37B market cap is too high, despite COVID-19 vacc...

‘Promising’ data on Oxford/AZ, CanSino coronavirus vaccines

Japan trials app to help coronavirus patients recover at hom...

Synairgen's inhaled drug cuts chances of COVID-19 progressin...

Call for COVID-19 'challenge trial' ahead of AstraZeneca vac...

Coronavirus pharma news roundup - 17/07/20

On genomics, NGS, and doing much more good than bad, with Ma...

How to meet your physicians where they are online

Coronavirus

Editor's Picks